Bcl-2-IN-13
Bcl-2-IN-13 is a Bcl-2 inhibitor with an IC50 value of 17 nM. Bcl-2-IN-13 can be used in cancer research[1].
Product Specifications
CAS Number
[1421687-31-1]
UNSPSC
12352005
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcl-2-in-13.html
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(N[C@H](CCN(C)C)CSC2=CC=CC=C2)C([N+]([O-])=O)=C1)(NC(C3=C4C=C(N5CCN(CC6=C(C7=CC=C(Cl)C=C7)C=CC=C6)CC5)C=C3)=NS4(=O)=O)=O
Molecular Formula
C42H44ClN7O6S3
Molecular Weight
874.49
References & Citations
[1]Ismail HS, et al. Design, molecular modelling and synthesis of novel benzothiazole derivatives as BCL-2 inhibitors. Sci Rep. 2023 Sep 20;13 (1) :15554.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7171954 Inquire
Rabbit anti-Escherichia coli (strain SE11) YOHJ Polyclonal Antibody
Ask
View Details 128385-AP 100 µL
IL12RB1 (Interleukin-12 Receptor Subunit beta-1, IL-12 Receptor Subunit beta-1, IL-12R Subunit beta-1, IL-12R-beta-1, IL-12RB1, IL-12 Receptor beta Component, CD212, IL12R, IL12RB, MGC34454) (AP) discontinued
Ask
View Details 
